JACOBS LEVY EQUITY MANAGEMENT, INC

Position in KURA — Kura Oncology, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in KURA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,410,244

+$5,514,106 QoQ

Shares Held

948,974

+57.6% QoQ

Ownership

1.07%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#23

of 220 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 71% Shared 0% None 29%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. KURA ranks #15 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,410,244	948,974	+57.6%	Shares	Sole	2026-08-14
2026-03-31	$4,896,138	602,231	-70.2%	Shares	Sole	2026-05-15
2025-12-31	$21,012,039	2,022,333	-9.1%	Shares	Sole	2026-02-13
2025-09-30	$19,687,621	2,224,590	+101.6%	Shares	Sole	2025-11-17
2025-06-30	$6,366,398	1,103,362	-28.5%	Shares	Sole	2025-08-14
2025-03-31	$10,191,145	1,544,113	+57.9%	Shares	Sole	2025-05-15
2024-12-31	$8,517,683	977,920	+5455.7%	Shares	Sole	2025-02-14
2020-03-31	$175,139	17,602	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.